Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, especially for cancers where cure alternatives remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline https://financefeeds.com/investor-closes-516-million-bitcoin-position/